Brilinta (ticagrelor)

pCPA File Number: 20714
Negotiation Status:
Concluded with an LOI
Indication(s):
Thrombotic events in Acute Coronary Syndromes, Prevention
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CDA-AMC Project Number:
SR0234-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: